The role of nuclear medicine in the diagnosis of Erdheim–chester disease. A series of clinical observations

Erdheim–Chester disease (ECD) is a rare disease with a poor prognosis. The first two cases were reported by Jakob Erdheim and William Chester in 1930. The etiology and disease incidence are unknown. One of the main components of this disorder is a chronic uncontrollable inflammation. In 2016 ECD was classified as histiocytic neoplasm by the World Health Organization and was categorized as “tumors of histiocytes and dendritic cells”. More than half of patients testing positive for the BRAF mutation. The final diagnosis is made on the basis of histological finding. There are radiological markers indicating a possible association with the disease. This is a specific, almost pathognomonic scintigraphic picture of the skeleton, “coated” aorta, “hairy” kidney patterns on computer tomography. There is a Erdheim–Chester Disease Global Alliance (ECDGA), which try to unite and provide with information about diagnostics and treatment of this rare disease both patients and doctors. Today, there are 571 registered patients and only one from Russia. We demonstrate three clinical cases of patients with newly diagnosed ECD and the role of nuclear medicine methods in assessing the prevalence of this disease.

Erdheim–Chester disease, single-photon emission computed tomography combined with computed tomography, positron emission tomography combined with computed tomography, rare clinical case

1. Tran T.A., Fabre M., Pariente D. et al. Erdheim–Chester disease in childhood: a challenging diagnosis and treatment. J Pediatr Hematol Oncol 2009;31(10):782–6. DOI: 10.1097/MPH.0b013e3181b76827.

2. Vallonthaiel A.G., Mridha A.R., Gamanagatti S. et al. Unusual presentation of Erdheim–Chester disease in a child with acute lymphoblastic leukemia. World J Radiol 2016;8(8):757–63. DOI: 10.4329/wjr.v8.i8.757.

3. Campo E., Harris N.L., Jaffe E.S. et al. WHO Classification of tumours of haematopoietic and lymphoid tissues. International Agency for Research on Cancer 2017. P. 586.

4. Emile J.F., Charlotte F., Amoura Z., Haroche J. BRAF mutations in Erdheim– Chester disease. J Clin Oncol 2013;31(3): 398. DOI: 10.1200/JCO.2012.46.9676.

5. Emile J.F., Diamond E.L., HéliasRodzewicz Z. et al. Recurrent RAS and PIK3CA mutations in Erdheim–Chester disease. Blood 2014;124(19):3016–9. DOI: 10.1182/blood­2014­04­570937.

6. Diamond E.L., Abdel­Wahab O., Pentsova E. et al. Detection of an NRAS mutation in Erdheim–Chester disease. Blood 2013;122(6):1089–91. DOI: 10.1182/blood­2013­02­482984.

7. Chester W. Uber Lipoid granulomatose. Virchows Arch (Pathol Anat Phys) 1930;279:561–602.

8. http://erdheim­chester.org.

9. Haroche J., Arnaud L., Amoura Z. Erdheim–Chester disease. Curr Opin Rheumatol 2012;24(1):53–9. DOI: 10.1097/BOR.0b013e32834d861d.

10. http://www.histio.org.

11. Dion E., Graef C., Miquel A. et al. Bone involvement in Erdheim–Chester disease: imaging findings including periostitis and partial epiphyseal involvement. Radiology 2006;238(2):632–9. DOI: 10.1148/radiol.2382041525.

12. Scolaro J.C., Peiris A.N. The Hairy Kidney of Erdheim–Chester Disease. Mayo Clin Proc 2018;93(5):671. DOI: 10.1016/j.mayocp.2018.03.003.

13. Kraniotis P., Daoussis D. Periaortitis, hairy kidneys and bone lesions. Rheumatology (Oxford) 2016;55(12):2118. DOI: 10.1093/rheumatology/kew331.

14. Lee H.J., Lee K.Y., Shin D.Y. et al. A Case of Erdheim–Chester disease with asymptomatic renal involvement. Cancer Res Treat 2012;44(2):146–50. DOI: 10.4143/crt.2012.44.2.146.

15. Serratrice J., Granel B., De Roux C. et al. “Coated aorta”: a new sign of Erdheim–Chester disease. J Rheumatol 2000;27(6):1550–3.

16. Ambrosini V., Savelli F., Merli E. et al. F­18 FDG PET/CT detects muscle involvement in Erdheim–Chester disease. Clin Nucl Med 2012;37(2):196–7. DOI: 10.1097/RLU.0b013e31823e9d54.

17. Martineau P., Pelletier­Galarneau M., Zeng W. The imaging findings of Erdheim–Chester disease: a multimoda lity approach to diagnosis and staging. World J Nucl Med 2017;16(1):71–4. DOI: 10.4103/1450­1147.181149.

18. Sabino D., do Vale R.H.B., Duarte P.S. et al. Complementary findings on 18F­FDG PET/CT and 18F­NaF PET/CT in a patient with Erdheim–Chester disease. Radiol Bras 2017;50(3):202–3. DOI: 10.1590/0100­3984.2015.0172.

19. Nicolazzi M.A., Carnicelli A., Fuorlo M. et al. Cardiovascular involvement in Erdheim–Chester disease: a case report and review of the literature. Medicine (Baltimore) 2015t;94(43):e1365. DOI: 10.1097/MD.0000000000001365.

20. Cives M., Simone V., Rizzo F.M. et al. Erdheim–Chester disease: a systematic review. Crit Rev Oncol Hematol 2015;95(1):1–11. DOI: 10.1016/j.critrevonc.2015.02.004.